We are a development stage company. We have not at any time been able to generate sufficient revenue from sales of our products or services to sustain ongoing operations. From inception on July 1, 2005 to December 31, 2008, we have generated total revenues of only $164,502 but as of December 31, 2008, we have incurred total operating expenses of $367,750 and an accumulated deficit of $223,416 since inception. We may continue to incur significant additional operating losses as our operations continue. Operating losses may fluctuate from quarter to quarter as a result of differences in the timing of expenses incurred and revenue recognized.
Source: SEC Form 10Q (For the quarterly period ended December 31, 2008)
As of December 31, 2008, we had a working deficit of $103,766, our deficit accumulated during the development stage was $223,416. For the period ended December 31, 2008, we had cash of $1,806. Our capital requirements relating to the manufacturing and marketing of our products have been, and will continue to be, significant. We are dependent on the proceeds of future financing in order to continue in business and to develop and commercialize proposed products. We anticipate requiring approximately $250,000 to $500,000 in additional financing for the next twelve months.
GoldMedical Products/Svcs.